Non-coding RNAs in cancer brain metastasis

Kerui Wu1, Sambad Sharma2, Suresh Venkat3

  • 1Wake Forest School of Medicine; Departments of Cancer Biology ; Winston Salem, NC, USA.

Insights

Brain metastasis is a major cause of cancer death, with increasing incidence despite new therapies. This review explores non-coding RNAs and extracellular vesicles in brain metastasis and their clinical potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Brain metastasis is a significant cause of cancer mortality, with increasing incidence.
  • The blood-brain barrier limits therapeutic drug efficacy, making the brain a sanctuary site for cancer cells.
  • Understanding the mechanisms of brain metastasis is crucial for developing effective treatments.

Purpose of the Study:

  • To review the pathophysiology of brain metastases.
  • To highlight the role of non-coding RNAs in cancer brain metastasis.
  • To discuss extracellular vesicles in cancer cell-microenvironment communication and clinical translation.

Main Methods:

  • Literature review of pathophysiology and molecular mechanisms.
  • Focus on non-coding RNAs and extracellular vesicles.
  • Discussion of computational and epigenetic aspects.

Main Results:

  • Non-coding RNAs play critical roles in the development and progression of brain metastases.
  • Extracellular vesicles facilitate intercellular communication, influencing the tumor microenvironment.
  • Computational and epigenetic factors are key to understanding non-coding RNA regulation in brain metastasis.

Conclusions:

  • Non-coding RNAs and extracellular vesicles represent promising targets for diagnosing and treating brain metastases.
  • Further research into the clinical translation of these findings is warranted.
  • Interdisciplinary approaches combining molecular biology, computational analysis, and epigenetics are essential.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.8K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K